CHANGE IN RATINGS
( ATHR) upgraded at Deutsche Bank to Buy from Hold. Management sees top line growth, improving PC trends, and share gains across product lines. Raised price target to $25 from $17.
downgraded at RBC to Sector Perform from Outperform based on current valuation and trading near proposed price target. Maintained price target of $50.
upgraded at Citigroup. Rating raised to Buy from Hold. Raising price target to $37 from $35. 2009 EPS estimates lowered to $3.23 from $3.26.
downgraded at Credit Suisse to Neutral from Outperform. Cites seasonal downturn in gold prices, valuation, and a possible takeover of SGX. Maintained price target of $10.50.
upgraded at FBR to Outperform from Market Perform. Speculations of rapid growth for 2010 and the possibility of a major contract in Brazil led to the upgrade. Raised price target to $51 from $33.
upgraded at RBC to Sector Perform from Underperform. Beliefs of strong post-recession results and current valuation led to the increase in ratings. Maintained price target of $5.
upgraded at Bernstein from Market Perform to Outperform. $176 price target. Expect fixed-income revenue to grow.
( KET) upgraded at RBC to Top Pick from Sector Perform. The progress of capital raising and current valuation which overestimates risk associated with rising credit deterioration prompted the upgrade. Raised price target to $6.50 from $6.00.
upgraded at Jefferies. Rating raised to Buy from Hold. Price target raised to $25.00 from $22.50. 2009 EPS estimates raised from $2.00 from $2.25.
rated new Buy at Deutsche Bank. $28 price target. Company is positioned well to grow within a multi-year transmission upgrade cycle.
upgraded at FBR to market perform from underperform and price target increased to $15 from $12. Upgrade due to stock valuation which better reflects the risks associated with the growing bank credit losses.
downgraded at Nomura to Neutral from Buy based on valuation. Increased price target to $62.80 from $56.
rated new Hold at Jefferies. $38 price target. Company has strong ROIC, but recent outperformance may not be sustainable.
STOCK COMMENTS / EPS CHANGES
estimates, target increased at Oppenheimer to $160 a share. Estimates also boosted, to reflect strong sales across multiple product lines. Outperform rating.
( ABDE) target raised at Morgan Stanley to $34. Company is cutting costs and could benefit from a recovery in advertising spending. Overweight rating.
estimates, target raised at UBS through 2010. Company is likely to grow faster than its peers over the near term and is reducing expenses. Neutral rating and new $27 price target.
( BUCY) target boosted at Merrill/BofA to $35. JOYG posted strong numbers that bode well for the entire group. Buy rating.
target raised at Citigroup to $375 a share. Company stands to grow revenue through interest rate swaps clearing and a recovery in interest rate futures trading. Buy rating.
estimates, target raised at Barclays to $78. Estimates also increased, as comp sales guidance appears achievable. Equal-weight rating.
price target raised at Goldman Sachs to $27 from $20 based on increased earnings expectations and higher market multiples. Company announced cost cuts totaling $40 million in 2009 and $50 million in 2010. See potential for improved gross margins as inventories realign. Maintained Neutral rating.
estimates through 2010, target boosted at UBS. Company has received a higher valuation, but travel demand remains soft. Neutral rating and new $18.50 price target.
target raised at Citigroup to $580. Positive channel checks and cyclical factors point to earnings upside potential into 2010. Buy rating.
( JOYG) numbers increased at Barclays to $42. Estimates also raised, as new bookings and cost cutting should help drive profit growth. Overweight rating.
target boosted at UBS to $24 a share. Recent meeting with management suggests that more cost cuts are coming. Buy rating.
target raised at UBS to $24. Expect the stock to trade well ahead of the June 23 quarterly report. Buy rating.
Procter & Gamble
2010 estimates cut at Barclays because of higher marketing costs. Overweight rating and $60 price target.
target boosted at UBS to $34. Company should benefit from stronger oil prices. Buy rating.
target raised at Credit Suisse to $48 from $43. Pending a merger with Petro-Canada and improvements in their oil sands and in-situ operations have led to the increase in numbers. Maintained Outperform rating.
This article was written by a staff member of TheStreet.com.